Baroness Delyth Morgan, CEO of Breast Cancer Now, tells us about some of the things she's been part of in her 25 years with the charity, as well as how we are focusing more on people with secondary breast cancer.
In 2017, Jen received a de novo diagnosis of secondary breast cancer after experiencing some unusual symptoms. She tells us about the misconceptions she had about cancer, and how she's working with Breast Cancer Now to campaign for change.
Drugs are a cornerstone of treatment for breast cancer. We know that you may have questions about drug treatment following the transition period ending on 31 December 2020. We take a look at what this means for medicines supply, medicines licensing, and clinical trials.